The Chemours Company CC recently announced the launch of a full-scale product trial with NTT DATA and a leading regional ...

Chemours (NYSE:CC) is preparing to appoint the chief executive of Vision One Management Partners to its board in an effort to ...

Chemours, a global leader in delivering innovative performance chemistry, today announced the launch of a full-scale product trial with NTT DATA and a leading regional engineering firm, Hibiya ...

Chemours Co. plans to add the chief executive officer of Vision One Management Partners to its board as it seeks to avoid a ...

Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with ...

It is unclear what actions the Trump administration will take, if any, to protect the public against PFAS, linked to cancer and other health problems.

Company announced the launch of a full-scale product trial with NTT Data and a regional engineering firm, Hibiya Engineering, ...

The N.C. Department of Environmental Quality is continuing Chemours’ search for groundwater contamination beyond the Lower ...

North Carolina ordered Chemours to expand PFAS well testing, adding 150,000 homes in six counties, including Harnett and Hoke ...

In this article, we are going to take a look at where The Chemours Company (NYSE:CC) stands against the other mid-cap value stocks. Value investing remains a time-tested strategy that provides ...

Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Chemours in a research note issued to investors on ...

Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $19.00.